Cutaneous Angiosarcoma of the Breast

2021 ◽  
Author(s):  
Ines Alonso ◽  
Olatz Gorrino Angulo, MD ◽  
Monica Santamaria, MD
Keyword(s):  
Angiosarcoma Of The Breast

scholarly journals Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Yoko Suzuki ◽  
Kohei Taniguchi ◽  
Minami Hatono ◽  
Yukiko Kajiwara ◽  
Yuko Abe ◽  
...  
Keyword(s):  
Case Report ◽  
Angiosarcoma Of The Breast ◽  
Radiation Induced

scholarly journals Radiation-Associated Angiosarcoma of the Breast and Chest Wall Treated with Thermography-Controlled, Contactless wIRA-Hyperthermia and Hypofractionated Re-Irradiation

Cancers ◽  
2021 ◽  
Vol 13 (15) ◽  
pp. 3911
Author(s):  
Markus Notter ◽  
Emanuel Stutz ◽  
Andreas R. Thomsen ◽  
Peter Vaupel
Keyword(s):  
Local Recurrence ◽  
Background Radiation ◽  
Definitive Treatment ◽  
Resection Margins ◽  
Recurrence Rates ◽  
Rate Dependent ◽  
Angiosarcoma Of The Breast ◽  
Positive Resection Margins ◽  
Locally Recurrent ◽  
Tumor Extent

Background: Radiation-associated angiosarcoma of the breast (RAASB) is a rare, challenging disease, with surgery being the accepted basic therapeutic approach. In contrast, the role of adjuvant and systemic therapies is a subject of some controversy. Local recurrence rates reported in the literature are mostly heterogeneous and are highly dependent on the extent of surgery. In cases of locally recurrent or unresectable RAASB, prognosis is very poor. Methods: We retrospectively report on 10 consecutive RAASB patients, most of them presenting with locally recurrent or unresectable RAASB, which were treated with thermography-controlled water-filtered infrared-A (wIRA) superficial hyperthermia (HT) immediately followed by re-irradiation (re-RT). Patients with RAASB were graded based on their tumor extent before onset of radiotherapy (RT). Results: We recorded a local control (LC) rate dependent on tumor extent ranging from a high LC rate of 100% (two of two patients) in the adjuvant setting with an R0 or R2 resection to a limited LC rate of 33% (one of three patients) in patients with inoperable, macroscopic tumor lesions. Conclusion: Combined HT and re-RT should be considered as an option (a) for adjuvant treatment of RAASB, especially in cases with positive resection margins and after surgery of local recurrence (LR), and (b) for definitive treatment of unresectable RAASB.

Survival in Angiosarcoma of the Breast

JAMA ◽  
1978 ◽  
Vol 240 (8) ◽  
pp. 737
Author(s):  
Geoffrey L. Smoron
Keyword(s):  
Angiosarcoma Of The Breast

Radiation-induced angiosarcoma of the breast: case report and self-criticism of therapeutic approach

2002 ◽  
Vol 127 (5) ◽  
pp. 388-391 ◽  
Author(s):  
G Anania ◽  
P.C Parodi ◽  
A Sanna ◽  
E Rampino ◽  
E Marcotti ◽  
...  
Keyword(s):  
Case Report ◽  
Therapeutic Approach ◽  
Angiosarcoma Of The Breast ◽  
Radiation Induced

Magnetic resonance imaging appearances in primary and secondary angiosarcoma of the breast

2013 ◽  
Vol 58 (2) ◽  
pp. 208-212 ◽  
Author(s):  
Ailbhe C O'Neill ◽  
Clare D'Arcy ◽  
Enda McDermott ◽  
Ann O'Doherty ◽  
Cecily Quinn ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Resonance Imaging ◽  
Angiosarcoma Of The Breast ◽  
Secondary Angiosarcoma

scholarly journals Primary epithelioid angiosarcoma of the breast masquerading as carcinoma

2010 ◽  
Vol 17 (1) ◽  
Author(s):  
S. Muzumder ◽  
P. Das ◽  
M. Kumar ◽  
S. Bhasker ◽  
C. Sarkar ◽  
...  
Keyword(s):  
Epithelioid Angiosarcoma ◽  
Angiosarcoma Of The Breast

scholarly journals Radiation-induced angiosarcoma of the breast: a retrospective analysis of 15 years' experience at an oncology center

2018 ◽  
Vol 51 (5) ◽  
pp. 281-286 ◽  
Author(s):  
Ines Alves ◽  
José Carlos Marques
Keyword(s):  
Latency Period ◽  
Distant Metastases ◽  
High Recurrence Rate ◽  
Imaging Features ◽  
Palpable Mass ◽  
Median Period ◽  
Angiosarcoma Of The Breast ◽  
Radiation Induced ◽  
High Index Of Suspicion ◽  
Oncology Center

Abstract Objective: To characterize a population of patients with radiation-induced angiosarcoma (RIAS) of the breast treated at an oncology center, focusing mainly on the imaging features, although also on the clinical presentation, diagnosis, and management. Materials and Methods: We performed a retrospective review of patients with histologically proven angiosarcoma of the breast or chest wall, all of whom received radiotherapy, after conservative or radical breast surgery, between 2000 and 2015. Results: Eleven patients met the inclusion criteria. The median age at the time of diagnosis of RIAS of the breast was 71.5 years (range, 58-87 years), and the median latency period was 8.9 years (range, 4-27 years). The rate of local recurrence was 54.4%, RIAS recurring after a median period of 10 months (range, 3-18 months), and distant metastases occurred in three patients (27.3%). All of the tumors were accompanied by skin changes, and a palpable mass was seen in four. Most of the imaging findings were nonspecific. Six patients underwent magnetic resonance imaging, which revealed pronounced skin enhancement in all six. Ultrasound-guided core needle biopsies were negative in three of the eight patients. Conclusion: RIAS of the breast is a rare but recognized complication of radiotherapy for breast carcinoma, with a poor prognosis and high recurrence rate, which requires a high index of suspicion for a prompt diagnosis.

scholarly journals Primary angiosarcoma of the breast— series of 11 consecutive cases— a single-centre experience

2018 ◽  
Vol 25 (1) ◽  
pp. 50 ◽  
Author(s):  
M. Kunkiel ◽  
M. Maczkiewicz ◽  
A. Jagiello-Gruszfeld ◽  
Z. Nowecki
Keyword(s):  
Chest Wall ◽  
Treatment Modality ◽  
Treatment Guidelines ◽  
Clinical Situation ◽  
Single Centre ◽  
Primary Angiosarcoma ◽  
Single Centre Experience ◽  
Angiosarcoma Of The Breast ◽  
Unfavourable Prognosis

Angiosarcomas of the breast are rare parenchymal malignancies of the chest wall. Surgery is the main treatment modality with chemotherapy and radiotherapy used in case of recurrence. With generally unfavourable prognosis and lack of clear treatment guidelines due to its rarity and scarcity of available data, angiosarcoma of the breast is a challenging clinical situation for both oncologist and patient. We present here the results of a series of 11 consecutive primary angiosarcoma cases treated at our institute between 2000 and 2015.

Chemotherapy for Angiosarcoma of the Breast: Case Report of 30-Year Survival and Analysis of the Literature

1994 ◽  
Vol 12 (2) ◽  
pp. 145-155 ◽  
Author(s):  
Lewis R. Silverman ◽  
Liane Deligdisch ◽  
John Mandeli ◽  
Ezra M. Greenspan
Keyword(s):  
Case Report ◽  
Angiosarcoma Of The Breast
Sign in / Sign up

Export Citation Format

Share Document